A phase I study of ATTR-01, a novel oncolytic adenovirus targeting αvβ6 integrin, which expresses the anti-PD-L1 antibody payload in tumour following intravenous delivery in patients with selected epithelial tumours

ATTR-01 - Accession Therap

https://cslide.ctimeetingtech.com/esmo2025/attendee/confcal_2/presentation

A. Samson1; E. Calvo2; T.C. Hernandez Guerrero3; M. Meissner4; V. Moreno Garcia5; E.E. Parkes6; P. Spiliopoulou7; P. Donaldson8; J. Decesare8; D. Krige9; H. Pandha8

Jul 30, 2025